$3.22
0.030.94%
Ult. Agg.: Oct 21, 4:00 PM
$3.22
0.030.94%
LENZ Therapeutics (LENZ) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.10 | $-1.08 | $-0.91 | $-0.68 |
| Actual | $-1.02 | $-1.32 | $-1.16 | $-0.59 |
| Surprise | +7.27% | -22.2% | -27.5% | +13.2% |
| Revenue | ||||
| Estimate | $2.3M | $1.7M | $3.8M | $5.4M |
| Actual | $5.5M | $1.9M | $1.6M | $12.5M |
| Surprise | +134.1% | +9.43% | -57.8% | +132.1% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.96 | $-0.91 | $-0.70 | $-0.62 |
| Revenue | ||||
| Consensus | $4.4M | $5.1M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-1.02 | $-1.10 | 7.27 % |
| Q1 | May 11, 2026 | $-1.32 | $-1.08 | -22.2 % |
| Q4 | Mar 24, 2026 | $-1.16 | $-0.91 | -27.5 % |
| Q3 | Nov 5, 2025 | $-0.59 | $-0.68 | 13.2 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $5.49M | $2.34M | 134.1 % |
| Q1 | May 11, 2026 | $1.90M | $1.74M | 9.43 % |
| Q4 | Mar 24, 2026 | $1.59M | $3.76M | -57.8 % |
| Q3 | Nov 5, 2025 | $12.50M | $5.39M | 132.1 % |